Accès ouvert
2024
article
OpenAlex
Chiara Montironi, Zhenghao Chen, Ingrid A. M. Derks, Gaspard Cretenet et autres
The tumor suppressor p53 has been described to control various aspects of metabolic reprogramming in solid tumors, but in B cell malignancies that role is as yet unknown. We generated pairs of p53 functional and knockout (KO) clones from distinct B cell …
nl
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Helga Simon‐Molas, Chiara Montironi, Gaspard Cretenet, Sjoerd P.P. van Eeden et autres
The amino acid transporter ASCT2, encoded by the gene SLC1A5, is the main glutamine importer in proliferating human and mouse cells. We recently showed that glutamine is the main fuel of the tricarboxylic acid (TCA) cycle in cells from chronic lymphocytic leukemia …
nl, it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Zhenghao Chen, Gaspard Cretenet, Valeria Carnazzo, Helga Simon‐Molas et autres
CD40 signaling upregulates BCL-XL and MCL-1 expression in the chronic lymphocytic leukemia (CLL) lymph node microenvironment, affording resistance to the BCL-2 inhibitor, venetoclax. Venetoclax resistance in the therapeutic setting and after long-term laboratory selection has been linked to metabolic alterations, but the …
nl, us, it
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Zhenghao Chen, Helga Simon‐Molas, Gaspard Cretenet, Beatriz Valle‐Argos et autres
Altered metabolism is a hallmark of both cell division and cancer. Chronic lymphocytic leukemia (CLL) cells circulate between peripheral blood (PB) and lymph nodes (LNs), where they receive proliferative and prosurvival signals from surrounding cells. However, insight into the metabolism of LN …
nl, us, gb
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Zhenghao Chen, Helga Simon‐Molas, Gaspard Cretenet, Beatriz Valle‐Argos et autres
Abstract Introduction: For chronic lymphocytic leukemia (CLL), especially in the lymph node (LN) setting where cells receive proliferative and pro-survival signals, in-depth studies of altered metabolism and its relationship with therapeutic responses are still lacking. Venetoclax, a BCL-2 inhibitor currently in wide …
nl, gb
(code pays fourni par la source)
2020
article
OpenAlex
Zhenghao Chen, Gaspard Cretenet, Beatriz Valle‐Argos, Francesco Forconi et autres
Introduction. Altered metabolism is one of the hallmarks of cancer. CLL cells circulate between peripheral blood (PB) and lymph nodes (LN) which necessitates high metabolic plasticity. In LN, CLL cells receive proliferative and pro-survival signals from surrounding cells, and become metabolically activated. …
nl, gb
(code pays fourni par la source)
2020
conference-abstract
OpenAlex
Zhenghao Chen, Gaspard Cretenet, Valeria Carnazzo, Gerritje J. W. van der Windt et autres
Alterations in expression of specifically BCL-XL and MCL-1 dictate sensitivity of CLL cells to the Bcl-2 specific inhibitor venetoclax (VEN). We and others have shown upregulation of these anti-apoptotic proteins by interaction of CLL cells with CD4+ T helper cells within their …
nl, it
(code pays fourni par la source)
2019
conference-abstract
OpenAlex
Zhenghao Chen, Gaspard Cretenet, Hanneke ter Burg, Gabriela Andrejeva et autres
Chronic lymphocytic leukemia (CLL) has become a paradigm for a cancer that depends on signals from the microenvironment. In lymph nodes (LN), CLL cells receive from surrounding cells proliferative and pro-survival signals, which can protect against chemotherapy and also the Bcl-2 inhibitor …
nl, us, gb
(code pays fourni par la source)
2015
article
OpenAlex
Yantao Liang, Yongyu Zhang, Chao Zhou, Zhenghao Chen et autres
cn
(code pays fourni par la source)